Cytovas Overview

  • Founded

  • 2010

Founded
  • Status

  • Out of Business

  • Latest Deal Type

  • Out of Business

Cytovas General Information

Description

Developer of an informatics platform designed to analyze flow cytometry data. The company's platform Cloud Cytomics, mine flow cytometry data to identify correlations between cellular biomarkers and disease, enabling clinicians and drug developers an automated mining, analysis and interpretation of flow cytometry cell-based biomarker data.

Contact Information

Website
www.cytovas.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA
  • United States
+1 (267) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytovas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Feb-2019 00000 Completed Out of Business
5. Later Stage VC 01-Jun-2017 0000 00000 Completed Generating Revenue
4. Grant 01-Jan-2014 00000 00000 Completed Startup
3. Accelerator/Incubator 05-Oct-2012 00000 00000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Cytovas’s complete valuation and funding history, request access »

Cytovas Patents

  • 22

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Cytovas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2646577-A2 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents Withdrawn 29-Nov-2010 0000000000
US-20120214679-A1 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents Abandoned 29-Nov-2010 0000000000
US-20120065912-A1 Calibration device and methods for use with a liquid handler Abandoned 09-Sep-2010 00000000000 0
CA-2751786-A1 Calibration device and methods for use with a liquid handler Abandoned 09-Sep-2010 00000000000
US-20110207119-A1 Methods for predicting a cancer patient's response to sunitinib Abandoned 22-Feb-2010 G01N33/5011 0
To view Cytovas’s complete patent history, request access »

Ready to get started?

Request a free trial